Insider transactions

Parsa Kiai

CIK 1766850 · last filed 2026-08-28

Parsa Kiai is a corporate insider who has filed 16 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider bought $529.2K of MED on Aug 28, 2026. Across all open-market trades the lifetime net is +$1.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $8.4M across reported positions. 32 SEC filings were submitted jointly with Steamboat Capital Partners, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.36M

Companies

2

Total Filings

16

Lifetime Open-Market Net

$1.50M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address
420 LEXINGTON AVENUE
SUITE 2300
NY, NY 10170
Related Filers
Steamboat Capital Partners, LLC — 32 joint filings, latest 2023-11-09
Steamboat Capital Partners II LP — 3 joint filings, latest 2020-05-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MED Director 719,172 $11.61 $8.35M $1.42M 4 2026-08-28
WHLRP 10%+ Owner 623 $8.96 $5.6K $76.4K 12 2022-11-30

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-28 MED Buy (P) +43,150 $529.2K EDGAR
2026-08-26 MED Buy (P) +4,329 $51.9K EDGAR
2026-08-21 MED Buy (P) +72,487 $842.7K EDGAR
2026-05-28 MED Grant (A) +19,317 $0 EDGAR
2022-11-30 WHLRP Buy (P) +12,916 $24.3K EDGAR
2022-11-15 WHLRP Buy (P) +30,502 $52.1K EDGAR
2022-09-02 WHLRP Sell (S) — $0 EDGAR
2021-12-09 WHLRP Sell (S) — $0 EDGAR
2021-12-03 WHLRP Sell (S) — $0 EDGAR
2021-12-01 WHLRP Sell (S) — $0 EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.